Premaitha Health has signed an agreement to offer the IONA test across Egypt. As a result of, Premaitha has secured its first Egyptian customer, a private reference testing laboratory, located in Cairo.
Premaitha didn’t disclose the name of the client in their press release. It said it expect the Laboratory to be be fully installed by the end of Q2 2018 and will provide the IONA test to its network of hospitals and clinics across the greater Cairo region. With a population of over 20 million people in Cairo alone – and approximately 2.8 million births every year in Egypt – the unnamed partner plans to establish additional installed laboratories for the IONA test in other strategic locations, Premaitha said.
Dr Stephen Little, CEO of Premaitha Health, said: “We are delighted to enter another country, particularly one with both a significant population and an appetite for high quality genetic screening. Today’s announcement is further demonstration of delivering against our strategy of geographic diversification. We look forward to working closely with our new partner in Egypt, which we hope will become another significant market for Premaitha.”